Study in bowel tumour patients suggests radiotherapy responses may be improved with targeted immunotherapy

Study (n=53) found that by profiling the immune landscape of cancers before therapy, researchers could identify which patients are likely to respond to radiotherapy, and also who might benefit from ‘priming’ their tumour with immunotherapy.

Source:

PharmaTimes